Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-19-060380

President and CEO sold 142,409 shares at an average $16.95 ($2,413,729)

  • President and CEO acquired 175,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Polymeropoulos Mihael Hristos · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-11 Exercise or conversion : show line 1 in the form +89,199 $10.65 $949,969 1,300,654 D
2019-12-11 Sale : show line 2 in the form −72,373 $16.92 $1,224,377 1,228,281 D
2019-12-12 Exercise or conversion : show line 3 in the form +85,801 $10.65 $913,781 1,314,082 D
2019-12-12 Sale : show line 4 in the form −70,036 $16.98 $1,189,351 1,244,046 D
Open-market sales · 142,409 sh · avg $16.95 · $2,413,729

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-12-11 Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) −89,199 85,801 D
2019-12-12 Exercise or conversion : show line 6 in the form Employee Stock Option (Right to Buy) −85,801 0 D
Loading xslF345X03/doc4.xml…